MI
Mirum Pharmaceuticals, Inc.
MIRM · NASDAQ
$93.90 -3.76% (-$3.67)
1M -5.94%
Market Cap $5.73B
P/E Ratio -
Div. Yield -
ROE 410.20%
Bulios Fair Price
$47.48
49.4% downside
Trenutna cena
$93.9
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MIRM trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 9.26x
PEG N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 30.36%
Rev. growth 89.13%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 17.42%
Gross margin 81.70%
FCF margin 74.13%
Quality
7 /100
Poor ROA 82.32%
ROIC 13.14%
Asset turnover 0.59x
Debt
43 /100
Moderate Int. coverage -59.74x
Current ratio 2.86x
Debt/Assets N/A
Stability
35 /100
Moderate EPS volatility 38.21%
Beta 0.49x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MIRM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher Peetz
Employees
433
Headquarters
Foster City
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report